Condition
Postherpetic; Neuralgia, Trigeminal (Etiology)
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Control Group
Research Leaders
7 sponsors active, led by Beijing Ditan Hospital
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Control Group1
- Mri After Ganglionic Local Opioid Analgesia Gloa1
- Esketamine Group1
Active Sponsors
- Beijing Ditan Hospital1
- The First Hospital of Fangshan District,Beijing1
- Hengshui People's Hospital1
- Klinikum Klagenfurt am Wörthersee1
- Beijing Xiaotangshan Hospital1
Top Investigators
Klinikum Klagenfurt am Wörthersee
Related Conditions
- Trigeminal Neuralgia Idiopathic1
- Glossopharyngeal Neuralgia1
- Atypical Facial Pain1